Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
prevention surgical practice linked to an active Biobanking infrastructure provides a wealth of tissue for ex vivo model development and high throughput compound testing. Candidate compounds can then be
-
maximise the performance and sustainability potential of construction products by using accelerated carbonation and bio-mineralisation to transform IBA into a valuable resource for the construction industry
-
to drive research outcomes. Collaborate internationally, including a planned one-year research visit to UGCT in Belgium. Publish high-impact research and contribute to future funding proposals. Why join us
-
). ACED is an international collaboration between the University of Manchester, University of Cambridge, University College London, the German Cancer Research Centre (DKFZ), Harvard University, and Oregon
-
disparities in post-discharge support. Focusing on high-burden CVD-related conditions it will assess: Improvements in primary care diagnosis coding completeness, consistency, and accuracy across diverse
-
team aiming to understand the biology and peritoneal metastasis of high grade serous ovarian cancer (HGSOC). We will combine cutting edge imaging approaches with mass spectrometry-based proteomics
-
experimental work exploring how people interpret data visualisations. The successful candidate will design, program, and deploy experiments using tools such as PsychoPy and Pavlovia to measure people’s
-
occupational health and/or occupational hygiene. The successful candidate will work in a highly experienced and multidisciplinary team to develop and deliver high quality and innovative teaching on our MSc and
-
community to cutting-edge equipment and highly skilled technical staff to ensure high-impact research and innovation as an outcome. Catalysing industrial collaboration and accelerating translation
-
. The programme is part of the International Alliance for Cancer Early Detection a £50m global partnership between CRUK, Dana Farber Cancer Institute, The University of Manchester, DKFZ, University College London